LAWRENCE, Mass., Sept. 30 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, and Robert S. Brown, Chief Financial Officer, will be presenting at the JMP Securities Healthcare Focus Conference on October 6, 2008 at Le Parker Meridien Hotel in New York.
NxStage's investor presentation is scheduled for Monday, October 6th at 2:30 p.m. ET. To listen to the audio webcast of the presentation during the event, please visit: http://www.nxstage.com and click on 'Investor Information.' A replay will be available for 30 days immediately following the live presentation.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.
This release contains "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995. All statements
contained in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended to
identify forward-looking statements. Examples of these forward-looking
statements include statements as to Mr. Burbank's and Mr. Brown's plans to
present at the JMP Securities Healthcare Focus Conference. NxStage
specifically disclaims any obligation to update these forward-looking
statements. These forward-looking statements should not be relied upon as
representing NxStage's expectations or beliefs as of any date subsequent to
the date of this press release.
Kristen K. Sheppard, Esq.
|SOURCE NxStage Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved